Regulatory involves authoring, compiling, and checking regulatory submissions and interacting directly with staff at regulatory bodies in line with the overall PhoenixTMG strategy.
Regulatory submissions for a clinical study will typically involve submitting documentation and data to a regulatory authority for review. This submission will generally include an application (Feasibility Questionnaire and CDA) for authorization, or it may be in response to a specific question raised during the review of the feasibility questionnaire process.
The outcome of the submission will determine whether or not a site can move beyond clinical trials into the Sponsor agreements.
The complexities of regulatory submission processes have long posed a challenge for smaller or emerging clinical sites and – more so recently. Submission requirements have become increasingly strict with applications requiring a significant amount of documentation and data.